It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
- DOI
- 10.1111/trf.12941
- Published
- 2015 Mar
- Container
- Transfusion
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/trf.12941,
title = {It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.},
author = {Sandler SG and Flegel WA and Westhoff CM and Denomme GA and Delaney M and Keller MA and Johnson ST and Katz L and Queenan JT and Vassallo RR and Simon CD and College of American Pathologists Transfusion Medicine Resource Committee Work Group},
year = {2015},
journal = {Transfusion},
doi = {10.1111/trf.12941},
url = {https://doi.org/10.1111/trf.12941}
}RIS
TY - JOUR TI - It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. AU - Sandler SG AU - Flegel WA AU - Westhoff CM AU - Denomme GA AU - Delaney M AU - Keller MA AU - Johnson ST AU - Katz L AU - Queenan JT AU - Vassallo RR AU - Simon CD AU - College of American Pathologists Transfusion Medicine Resource Committee Work Group PY - 2015 JO - Transfusion DO - 10.1111/trf.12941 UR - https://doi.org/10.1111/trf.12941 ER -
APA
SG, S., WA, F., CM, W., GA, D., M, D., MA, K., ST, J., L, K., JT, Q., RR, V., CD, S., & Group, C. O. A. P. T. M. R. C. W. (2015). It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.. Transfusion. https://doi.org/10.1111/trf.12941
Source records
- pubmed · retrieved 2026-09-27T01:56:18.890Z